#CancerNews hashtag - Bluesky

1 week ago

The treatment offers longer survival for some patients and can be combined with chemo, giving hope where options had barely changed since the 1990s. #CancerNews #Oncology #TCSC

1 0 0 0

Cancer Survivors Club 📙

@thecancersurvivorsclub.com

1 week ago

The decision, based on improved progression‑free survival over AVD alone, also converts some earlier accelerated approvals to traditional ones, cementing Opdivo’s role across relapsed and frontline Hodgkin settings. #CancerNews #Hematology #TCSC

2 0 1 0

Cancer Survivors Club 📙

@thecancersurvivorsclub.com

1 week ago

In the Beamion LUNG‑1 trial, zongertinib achieved a 76% response rate in untreated HER2‑mutant NSCLC, with many patients keeping responses beyond 6–12 months and tolerability described as manageable. #NSCLC #CancerNews #TCSC

0 0 0 0

Roman Piso

@romanpiso.bsky.social

1 month ago

A 20-year-old woman had waves of stomach pain for months. She was eventually diagnosed with stage 2 colon cancer. A 20-year-old woman experienced on-and-off stomach pain, then sudden nausea and chills. She was diagnosed with stage 2 colon cancer.

#Discover @paulinsc.bsky.social @hermes61.bsky.social #Health #Cancer #ColonCancer #MedicalNews #CancerNews #Women #Women'sHealth #CancerSymptoms #Doctors #HealthCoverage #Medicine

www.yahoo.com/news/article...

21 8 0 1

Cancer Survivors Club 📙

@thecancersurvivorsclub.com

2 months ago

DATROWAY® (datopotamab deruxtecan-dlnk) granted Priority Review in the US as 1st-line treatment for patients with metastatic triple-negative breast cancer who are not candidates for immunotherapy

The FDA has accepted and granted Priority Review to AstraZeneca and Daiichi Sankyo’s Datroway as a first-line option for adults with metastatic triple-negative breast cancer not eligible for immunotherapy! #TCSC #CancerNews #TNBC #FDA

www.astrazeneca-us.com/media/press-...

0 0 1 0

Roman Piso

@romanpiso.bsky.social

2 months ago

The deadliest cancer for people under 50 has changed for the first time in a decade, leaving experts shocked Experts say they're stunned by how quickly colon cancer has overtaken other deadly cancers, including lung and breast.

#Discover #News #Cancer #ColonCancer #Health #HealthNews #CancerNews #HealthWatch #Woman

www.yahoo.com/health/condi...

1 1 0 0

Cassie Briggs, PhD

@sciencecareercoach.bsky.social

2 months ago

📰 Today's Science News: Scientists find the colon may be more vulnerable to early-onset colorectal cancer due to chronic inflammation. Even in younger patients, healthy-appearing tissue was stiffer, suggesting changes happen before cancer develops. #sciencenews #sciencedaily #healthnews #cancernews

0 0 0 0

Future Timeline

@futuretimeline.bsky.social

2 months ago

NHS cancer gene database to allow families to check risk Thousands of people in England will be able to check whether they have genes linked to cancer.

NHS cancer gene database to identify patients at risk www.bbc.co.uk/news/article... #cancer #cancernews #cancerresearch #genetics

2 1 0 0

Cancer Survivors Club 📙

@thecancersurvivorsclub.com

3 months ago

New discovery in cancer signaling reveals a potential path to more effective cancer drugs A large, multi-institution study led by a Brown University physician-scientist could have important implications for the development of new classes of cancer therapeutics.

Scientists have uncovered a new way cancer cells send and receive growth signals, opening the door to more precise, effective cancer drugs that could make treatments smarter and kinder. #CancerNews #Oncology #CancerBreakthrough #ScienceMatters #TCSC www.brown.edu/news/2025-12...

1 0 0 0

Cancer Survivors Club 📙

@thecancersurvivorsclub.com

4 months ago

Study suggests many men may not need long-term hormone therapy for prostate cancer Shorter courses of androgen deprivation therapy could reduce risks while still effectively controlling cancer.

A new study suggests many men with prostate cancer may not need long-term hormone therapy. Researchers found most ADT benefits happen in the first 9–12 months. Smarter treatment, fewer side effects. #ProstateCancer #CancerResearch #TCSC #Oncology #CancerNews #ADT

newsroom.ucla.edu/releases/lon...

2 1 0 0

Cancer Survivors Club 📙

@thecancersurvivorsclub.com

4 months ago

Recycled nuclear fuel to produce targeted cancer therapies Sites in Preston and Cheshire are to develop cutting-edge technology for hard-to-treat cancers.

Recycled nuclear will soon power more than homes. A £9.9m project will turn it into cutting-edge therapies for hard-to-treat cancers. Science doing what science does best: saving lives in unexpected ways. #CancerResearch #Oncology #TCSC #CancerNews #MedicalBreakthrough

www.bbc.com/news/article...

0 0 0 0

Cancer Survivors Club 📙

@thecancersurvivorsclub.com

4 months ago

FDA approves pembrolizumab with enfortumab vedotin-ejfv On November 21, 2025, the Food and Drug Administration approved pembrolizumab (Keytruda, Merck) or pembrolizumab and berahyaluronidase alfa-pmph (Keytruda Qlex,

FDA approves pembrolizumab (Keytruda) with enfortumab vedotin-ejfv (Padcev) as a new neoadjuvant and adjuvant option for adults with muscle-invasive bladder cancer who can’t receive #cisplatin. #TCSC #CancerNews #BladderCancer #Immunotherapy #FDA

www.fda.gov/drugs/resour...

0 0 0 0